Stocks and Investing Stocks and Investing
Thu, March 31, 2022
[ 12:00 AM ] - WOPRAI
John Ransom Maintained (AVAH) at Strong Buy with Decreased Target to $8 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Abrahams Maintained (ATAI) at Hold with Decreased Target to $9 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Walkley Maintained (BB) at Hold and Held Target at $7 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Blayne Curtis Downgraded (AMD) to Hold and Decreased Target to $115 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Evan Seigerman Maintained (CADL) at Buy with Decreased Target to $12 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Scott Berg Maintained (BRZE) at Strong Buy with Decreased Target to $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Schwartz Maintained (BRZE) at Buy with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Brian Peterson Maintained (BRZE) at Buy with Decreased Target to $65 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
David Hynes Maintained (BRZE) at Strong Buy with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Derek Johnston Maintained (BRX) at Hold with Increased Target to $28 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Stephen Powers Initiated (BRCC) at Hold and Held Target at $19 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Devin Dodge Maintained (BIP) at Buy with Increased Target to $47 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Roger Read Upgraded (BKR) to Buy and Held Target at $43 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Chubak Downgraded (BK) to Hold and Held Target at $55 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Alexander Blostein Maintained (BK) at Hold with Decreased Target to $60 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Michael Ng Maintained (BLND) at Strong Buy with Decreased Target to $9 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Heiko Ihle Maintained (AREC) at Strong Buy with Increased Target to $4.5 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Joseph Feldman Maintained (ARHS) at Buy with Increased Target to $12 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Marc Goodman Maintained (AMLX) at Buy with Decreased Target to $31 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Paul Sankey Upgraded (APA) to Strong Buy and Increased Target to $56 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Do Kim Initiated (AFMD) at Buy and Held Target at $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Mark Devries Maintained (AER) at Buy with Decreased Target to $72 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Stathoulopoulos Maintained (AER) at B .. y with Decreased Target to $75 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Moshe Orenbuch Maintained (AER) at Buy with Decreased Target to $70 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Vincent Ciantic Maintained (AER) at Buy with Decreased Target to $74 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Steven Delaney Maintained (ACRE) at Buy with Increased Target to $17 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
David Dai Initiated (ACET) at Buy and Held Target at $28 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Amit Daryanani Maintained (AAPL) at Buy and Held Target at $210 on, Mar 31st, 2022
[ 12:00 AM ] - WOPRAI
Christopher Raymond Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022

Christopher Raymond Downgraded (AKBA) to Hold and Decreased Target to $2 on, Mar 31st, 2022


Published on 2024-10-27 20:14:52 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Downgraded "Akebia Therapeutics, Inc." (AKBA) to Hold and Decreased Target from $8 to $2 on, Mar 31st, 2022.

Christopher, nor any peers, have made any analyst calls on AKBA in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources